Study Reveals Political Affiliation Influences COVID-19 Vaccine Adverse Event Reporting
A recent study published in JAMA Network Open indicates that political affiliations may significantly influence the [...]
FDA Approves Merck’s Winrevair for Pulmonary Arterial Hypertension
The U.S. Food and Drug Administration (FDA) recently approved Winrevair, a new treatment developed by pharmaceutical [...]
Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy
A recent study highlighted in the journal Gastroenterology has unveiled potential concerns associated with GLP-1 diabetes [...]
Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers
A groundbreaking study conducted in Germany has unveiled three distinct subtypes of Multiple Sclerosis (MS), categorized [...]
Bristol Myers Squibb Announces Layoffs at Mirati Therapeutics Following Acquisition
Bristol Myers Squibb (BMS) has initiated a significant workforce reduction at the headquarters of the recently [...]
Switzerland’s Progressive Approach to Opioid Addiction Treatment: A Model for Success
In Zurich, Switzerland, the Arud Centre for Addiction Medicine offers a pioneering approach to opioid addiction, [...]
MilliporeSigma Announces Major Investment in South Korean Bioprocessing Plant
MilliporeSigma, the life science division of Merck KGaA, has committed to a significant expansion in Asia-Pacific [...]
Lenz Therapeutics Opts for Reverse Merger Ahead of Phase 3 Results
Lenz Therapeutics made its Nasdaq debut through a reverse merger, a strategic choice that CEO Eef [...]
Nvidia Unveils AI Microservices for Healthcare Innovation at GTC Conference
At its annual GTC conference, Nvidia introduced 25 generative AI microservices aimed at revolutionizing the healthcare [...]
Texas Medical Board Proposes Guidance on Legal Abortion in Medical Emergencies
The Texas Medical Board has released draft guidance aimed at clarifying when abortions are legally permissible [...]
Job Cuts at Bellus Health Following GSK’s $2 Billion Acquisition
In the wake of GSK's $2 billion acquisition of Bellus Health, an undisclosed number of Bellus [...]
Expanded Coverage for Anti-Obesity Drugs in U.S. Government Health Programs
The Centers for Medicare and Medicaid Services (CMS) has issued guidance for Medicare Part D plans [...]
U.S. Drug Overdose Deaths Hit Record High in 2022, Showing Signs of Stabilizing Crisis
The U.S. saw a record 107,941 drug overdose deaths in 2022, a slight rise from the [...]
The Evolution and Future of CAR-T Cell Therapies: Overcoming Manufacturing Hurdles for Cancer Treatment
In the summer of 2017, Novartis took a significant step in cancer treatment with the approval [...]
EPA’s Asbestos Ban: A Major Step Forward with Long-Term Public Health Implications
The Environmental Protection Agency (EPA) has announced a comprehensive ban on all forms of asbestos in [...]
AstraZeneca Acquires Fusion Pharmaceuticals for $2 Billion
AstraZeneca has announced a $2 billion acquisition of Fusion Pharmaceuticals, significantly investing in the burgeoning field [...]
UnitedHealth Advances $2 Billion to Providers After Cyberattack on Change Healthcare
UnitedHealth Group has distributed over $2 billion in advance payments to healthcare providers impacted by a [...]
EU Spearheads Real-World Evidence Projects to Revolutionize Healthcare Decision-Making
The European Union is in charge of integrating real-world evidence (RWE) and advanced data analytics into [...]
Zephyr AI Secures $111M in Series A Funding to Revolutionize Healthcare with AI
Zephyr AI, a US-based healthcare technology company, has successfully raised $111 million in a Series A [...]
FDA Outlines Regulatory Framework for AI in Medical Products
The FDA has published a comprehensive plan to regulate artificial intelligence (AI) in medical products, marking [...]
The Experimental Quest for Longevity: Rapamycin’s Rising Popularity
At 77, David Sandler from Bergen County, N.J., has ventured into an experimental approach to longevity [...]
AstraZeneca Boosts Rare Diseases Portfolio with Acquisition of Amolyt Pharma
AstraZeneca has announced a definitive plan on Thursday, March 14 to acquire Amolyt Pharma, a clinical-stage [...]
FDA Approves First Drug for Fatty Liver Disease by Madrigal Pharmaceuticals
The FDA has approved Madrigal Pharmaceuticals' Rezdiffra, the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), offering [...]
Amazon and Eli Lilly Partner for Telehealth Medication Delivery Amid Drug Shortages
Amazon has partnered with Eli Lilly to distribute select medications, including GLP-1 drugs Mounjaro and Zepbound, [...]
President Biden’s State of the Union: A Focus on Healthcare, Drug Pricing, and Reproductive Rights Amid Election Season
In his State of the Union address, President Joe Biden highlighted healthcare as a central priority, [...]